High-Dose CD20-Targeted Radioimmunotherapy-Based Autologous Transplantation Improves Outcomes for Persistent Mantle Cell Lymphoma

Autologous stem cell transplant (ASCT) can improve outcomes for mantle cell lymphoma (MCL) patients, yet relapses are frequent. We hypothesized that high-dose anti-CD20 radioimmunotherapy (RIT)-based conditioning could improve results in this setting. We thus assessed 162 consecutive patients with M...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Br J Haematol
Egile Nagusiak: Cassaday, Ryan D., Stevenson, Philip A., Gooley, Theodore A., Chauncey, Thomas R., Pagel, John M., Rajendran, Joseph, Till, Brian G., Philip, Mary, Orozco, Johnnie J., Bensinger, William I., Holmberg, Leona A., Shustov, Andrei R., Green, Damian J., Smith, Stephen D., Libby, Edward N., Maloney, David G., Press, Oliver W., Gopal, Ajay K.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2015
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4715476/
https://ncbi.nlm.nih.gov/pubmed/26455717
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.13773
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak